Since its development in the 1970s, total shoulder replacement has been favored by most surgeons for the management of primary osteoarthritis of the shoulder. While some studies have suggested that glenoid loosening is rare, long-term studies suggest that 50% of total shoulders will experience painful glenoid loosening if followed for greater than 10 years. The evidence of progressive radiolucent lines on the glenoid side in virtually all series is worrisome. Mid-term results of a prospective series of 47 shoulders undergoing hemiarthroplasty for primary osteoarthritis of the shoulder were presented in 1998. This study represents the continued long-term prospective study of this cohort. Follow-up averaged 8.7 years. Review both radiographic and clinical was done with careful assessment of the cause of failure. Non-concentric reduction was the most common cause of a fair or poor (9%), leading to asymmetric glenoid erosion. 8% of the failures were unclear, with normal radiographs at follow-up. At longer-term follow-up four additional patients developed pain; no further patients required revision surgery. A subset of four patients with hemiarthroplasty on one side and total shoulder were meticulously studied. At final follow-up the UCLA, ASES, VAS pain scores, and Simple Shoulder Test showed no significant differences in any subcategory for this unique subgroup of patients. Hemiarthroplasty is shown to provide satisfactory long-term results provided concentric reduction can be obtained in a high percentage of patients, consistent with Neer’s revision rate of zero for his own 20-year series of hemiarthroplasties. Long-term follow-up did not show a significant increase in revisions rates over mid-term results. While the failed hemiarthroplasty is often ascribed to the lack of a glenoid component, other factors such as soft tissue problems are equally likely. Careful soft tissue balancing with appropriate alteration of version of the component appears to allow good results permitting centering of the arthroplasty without placement of a glenoid component. Hemiarthroplasty appears to provide reasonably long-term results without the risk of late glenoid loosening, and may be preferable in the population where glenoid loosening is of concern. If noted, the author indicates something of value received. The codes are identified as follows: a, research or institutional support; b, miscellaneous funding; c, royalties; d, stock options; e, consultant or employee. *The Food and Drug Administration has not cleared the drug and/or medical device for the use described in this presentation (ie, the drug or medical device is being discussed for an “off-label” use). If noted, the author indicates something of value received. The codes are identified as follows: a, research or institutional support; b, miscellaneous funding; c, royalties; d, stock options; e, consultant or employee. *The Food and Drug Administration has not cleared the drug and/or medical device for the use described in this presentation (ie, the drug or medical device is being discussed for an “off-label” use). If noted, the author indicates something of value received. The codes are identified as follows: a, research or institutional support; b, miscellaneous funding; c, royalties; d, stock options; e, consultant or employee. *The Food and Drug Administration has not cleared the drug and/or medical device for the use described in this presentation (ie, the drug or medical device is being discussed for an “off-label” use).
Read full abstract